A Phase 1, Randomized, Open-Label, Crossover Study to Evaluate the Bioequivalence of Single Oral Dose of TAK-438ASA tablet and Single Oral Dose of TAK-438 tablet plus Aspirin Enteric-Coated tablet (Study 1) and the Food Effect of Single Oral Dose of TAK-438ASA tablet (Study 2) in Healthy Adult Male Subjects
Phase of Trial: Phase I
Latest Information Update: 20 Nov 2019
Price : $35 *
At a glance
- Drugs TAK-438ASA (Primary) ; Aspirin; Vonoprazan
- Indications Unspecified
- Focus Pharmacokinetics
- Sponsors Takeda
- 25 Oct 2018 Status changed from recruiting to completed.
- 12 Mar 2018 Status changed from not yet recruiting to recruiting.
- 05 Mar 2018 New trial record